MedTrace Logo

Outcomes of ICT Assistive Technology in RehabiliTAtIoN Pathways

NCT06546813 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-08-26

No results posted yet for this study

Summary

The study aims to improve the quality of prosthetic intervention and verify the adequacy of assistive devices, and measurement outcomes. Fifty patients in need of prosthetic interventions for Augmentative Alternative Communication, computer accessibility, and environmental control will be recruited within the DAT Unit of the Fondazione Don Carlo Gnocchi "IRCCS S.Maria Nascente" in Milan. At baseline (T0) a physician and a psychologist will perform a clinical evaluation and the AT outcome assessment. The participants will be contacted for the follow-up phase (T1) 3 to 6 months after having received the assistive solution. At T1 clinicians will readminister the AT outcome assessment. In order to make the assessment accessible to all participants, these tests and questionnaires will be administered on Windows PCs, using Grid3 software, or on a specifically created accessible web page.

Conditions

  • Communication Aids for Disabled
  • Communication Disorders
  • Motor Disorders
  • Cognitive Disorder

Interventions

OTHER

scales and questionnaire administration

evaluation of the quality of prosthetic intervention, verification of the adequacy of assistive devices, and outcomes measurement

Sponsors & Collaborators

  • Ministry of Health, Italy

    collaborator OTHER_GOV

  • Fondazione Don Carlo Gnocchi Onlus

    lead OTHER

Principal Investigators

  • Claudia Salatino · IRCCS Fondazione Don Carlo Gnocchi ONLUS

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2025-09-30
Completion
2025-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546813 on ClinicalTrials.gov